Genentech, a member of the Roche Group and pioneer of biotechnology, discovers and develops breakthrough medicines for serious diseases including cancer, neurological disorders, and ophthalmological conditions. Founded in 1976 as the world's first biotech company, it has delivered over 30 FDA-approved therapies. The company integrates AI end-to-end across its R&D ecosystem to accelerate drug discovery, clinical trials, and manufacturing.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountFeb 1990
Oct 1980
Apr 1976
Create a free account to see which investors have funded this company.
Create Free Account
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
